Current research on breathing liquids, particularly perfluorocarbons, indicates that experiments have successfully allowed rats to survive for up to 20 hours while breathing these substances. However, human trials remain limited, with significant challenges still present. Notably, highly oxygenated fluids are being administered to premature infants with underdeveloped lung capacity, showcasing a practical application of liquid breathing technology. The field continues to evolve, but comprehensive human testing is still in its infancy.
PREREQUISITESMedical researchers, neonatologists, respiratory therapists, and anyone interested in the advancements of liquid breathing technologies and their applications in critical care.